PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Omeprazole - Acid suppression (Adults)
PAD Profile : Omeprazole - Acid suppression (Adults)
Keywords :
GORD, gastro-oesophageal reflux disease, indigestion, PPIs, Proton pump inhibitors, gastric ulcer, stomach ulcer, dyspepsia
Brand Names Include :
Losec
Traffic Light Status
Status 1 of 3.
Status :
Green
Important
Preferred
Formulations :
- Capsules
Important Information :
1st line for patients with no swallowing difficulties.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 3.
Status :
Non Formulary
Important
Formulations :
- Tablets
Important Information :
Omeprazole or lansoprazole capsules are 1st-line.
Pantoprazole or rabeprazole tablets are 2nd-line for patients without swallowing difficulties (suitable for patients that cannot have animal-derived products).
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 3 of 3.
Status :
Non Formulary
Important
Formulations :
- Oral suspension
- Oro-dispersible
Important Information :
Omeprazole capsules can be opened for patients with swallowing difficulties.
Lansoprazole oro-dispersible tablets are 1st-line for patients with enteral feeding tubes
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Esomeprazole
- Ranitidine hydrochloride
- Lansoprazole
- Pantoprazole
- Rabeprazole sodium
- Cimetidine
- Nizatidine
- Famotidine
Other Indications
- Acid Suppression (Children)
- Acid Suppression (Children)
- Acid Suppression (Children)
- Gastric / Duodenal ulcer
- Zollinger-Ellison syndrome
- Gastric bleed
- Post endoscopy haemorrhage
Additional Documents
Type
Document
Review Date
Information
01 September 2025
Committee Recommendations
Date
Committee Name
Narrative
07 September 2022
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed that omeprazole capsules are a first choice option for people with no swallowing difficulties.
Most capsules can be opened, and granules dispersed in water (check individual SPC)
For people with no swallowing difficulties:
- 1st Line: Lansoprazole capsules/Omeprazole capsules
- 2nd line: Pantoprazole tablets (Suitable for patients that cannot have animal-derived products)
- 2nd line: Rabeprazole tablets (Suitable for patients that cannot have animal-derived products)
- 3rd line: Esomeprazole capsules – not for new initiation
For patients who cannot swallow tablets/have swallowing difficulties:
- 1st Line: lansoprazole orodispersible tablets
- 2nd line: lansoprazole capsules/omeprazole capsules (opened, and granules dispersed in water/yoghurt/apple puree)
- 3rd line: esomeprazole granule sachets
For patients with enteral feeding tubes:
- 1st line: lansoprazole orodispersible tablets
- 2nd line: lansoprazole capsules
- 3rd line: esomeprazole granule sachets (do not use if tube is less than 6F)
Associated BNF Codes
01. Gastro-Intestinal System
01.03.05. Proton pump inhibitors